Tianjin Pharmaceutical da Ren Tang Group Ltd 2022 SR
The report highlights Tianjin Pharmaceutical Da Ren Tang Group's commitment to innovative traditional Chinese medicine and sustainable development in 2022. The company achieved a total operating income of RMB 8,249 million and implemented 17 energy-saving projects, reducing consumption by 53.75 tons of standard coal. It maintained high quality standards with all industrial enterprises passing GMP certification and focused on R&D with an investment of RMB 151 million. Social contributions included significant anti-pandemic drug supplies and community donations. The group also emphasized employee well-being, achieving a 100% retention rate for employees returning from maternity leave.
Company: Tianjin Pharmaceutical da Ren Tang Group Ltd
Sector: Manufacturing
Country: China
Year: 2022
Type: SR
Pages: 49
Tianjin Pharmaceutical da Ren Tang Group Ltd
The report highlights Tianjin Pharmaceutical Da Ren Tang Group's commitment to innovative traditional Chinese medicine and sustainable development in 2022. The company achieved a total operating income of RMB 8,249 million and implemented 17 energy-saving projects, reducing consumption by 53.75 tons of standard coal. It maintained high quality standards with all industrial enterprises passing GMP certification and focused on R&D with an investment of RMB 151 million. Social contributions included significant anti-pandemic drug supplies and community donations. The group also emphasized employee well-being, achieving a 100% retention rate for employees returning from maternity leave.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jan 1, 2022 - Dec 31, 2022
Fiscal Year
2022
Published
Mar 30, 2023
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Energy Consumption
Water Consumption
Workplace Fatalities
Employees